11/19/2024
6:59 PM | Gall Matthew (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
8:57 AM | Boxer Capital Management, LLC (Filed by)
iTeos Therapeutics (Subject)
| Form SC 13D/A | |
11/18/2024
8:57 PM | Boxer Capital Management, LLC (Filed by)
iTeos Therapeutics (Subject)
| Form SC 13D/A | |
11/14/2024
5:04 PM | EcoR1 Capital, LLC (Filed by)
iTeos Therapeutics (Subject)
| Form SC 13G/A | |
11/12/2024
6:08 AM | iTeos Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2024
6:00 AM | iTeos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
8:49 PM | Boxer Capital, LLC (Filed by)
iTeos Therapeutics (Subject)
| Form SC 13D/A | |
|
10/15/2024
6:20 PM | Boxer Asset Management Inc. (Filed by)
iTeos Therapeutics (Subject)
| Form SC 13D/A | |
09/30/2024
8:00 AM | iTeos Therapeutics (Subject)
TANG CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13G | |
09/16/2024
6:00 AM | iTeos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
7:00 PM | Detheux Michel (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
6:08 AM | iTeos Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/05/2024
6:16 AM | Feltquate David (Reporting)
iTeos Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/05/2024
6:19 AM | Feltquate David (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
7:00 PM | Iannone Robert (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
7:00 PM | iTeos Therapeutics (Issuer)
RHOADS ANN D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
7:00 PM | DeSimone Jill (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
7:00 PM | Hallal David (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
7:00 PM | Davis Aaron I. (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
7:00 PM | iTeos Therapeutics (Issuer)
Lee David K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
7:00 PM | iTeos Therapeutics (Issuer)
Van Hauwermeiren Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
7:00 PM | Ho Tony W (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
3:01 PM | iTeos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
7:37 AM | Boxer Capital, LLC (Filed by)
iTeos Therapeutics (Subject)
| Form SC 13D/A | |
05/14/2024
8:32 PM | Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Davis Aaron I. (Reporting)
iTeos Therapeutics (Issuer)
LEWIS JOSEPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
8:06 PM | iTeos Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
8:10 PM | iTeos Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
05/13/2024
6:01 AM | iTeos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2024
3:35 PM | iTeos Therapeutics (Filer)
| Form 424B5 | |
05/10/2024
7:31 AM | iTeos Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/25/2024
6:13 AM | iTeos Therapeutics (Filer)
| Form ARS | |
04/25/2024
6:03 AM | iTeos Therapeutics (Filer)
| Form DEF 14A | |
04/25/2024
6:07 AM | iTeos Therapeutics (Filer)
| Form DEFA14A | |
03/08/2024
6:57 PM | Detheux Michel (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
6:58 PM | iTeos Therapeutics (Issuer)
McGrath Yvonne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
7:00 PM | Call Matthew (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
7:01 PM | Gall Matthew (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
7:00 PM | DeSimone Jill (Reporting)
iTeos Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/07/2024
7:01 PM | DeSimone Jill (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
6:09 AM | iTeos Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/06/2024
6:19 AM | iTeos Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad) As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential.
Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention. 👉 Click here to access your FREE report now! |
02/16/2024
11:54 AM | EcoR1 Capital, LLC (Filed by)
iTeos Therapeutics (Subject)
| Form SC 13G | |
02/14/2024
8:45 AM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
iTeos Therapeutics (Subject)
| Form SC 13G/A | |
01/10/2024
4:00 PM | iTeos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
3:26 PM | iTeos Therapeutics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
12/07/2023
7:20 PM | Detheux Michel (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
7:21 PM | Gall Matthew (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
7:22 PM | Call Matthew (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
7:22 PM | iTeos Therapeutics (Issuer)
McGrath Yvonne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
7:16 PM | iTeos Therapeutics (Issuer)
Lee David K (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/07/2023
7:17 PM | iTeos Therapeutics (Issuer)
Lee David K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
